Trials and tribulations in primary CNS lymphoma

Stephen Ansell and Vincent Rajkumar

A minority of patients with primary central nervous system lymphoma achieve a complete response to therapy andmost patients have a poor prognosis.A recent randomised phase II trial demonstrated that the addition of high-dose cytarabine to high-dosemethotrexate increases the complete response rate and improves patient outcome.

Download full article

Be the first to comment

Leave a Reply

Your email address will not be published.


*


UA-77507851-1